When was SonALAsense founded?

SonALAsense was founded in 2019 and raised its 1st funding round within a year of its incorporation.

Where is SonALAsense located?

SonALAsense is headquartered in Berkeley, United States.

Who is the current CEO of SonALAsense?

Stuart Marcus of SonALAsense. They have also founded 1 company.

How many employees does SonALAsense have?

As of Aug 31, 2026, the latest employee count at SonALAsense is 10.

Is SonALAsense a funded company?

SonALAsense is a funded company, having raised a total of $13.7M across 8 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jan 01, 2019.

When was the latest funding round of SonALAsense?

SonALAsense's latest funding was a $***** Grant (prize money) round on Apr 09, 2025, with participation from 1 investor. Its primary sector is Neurology. In United States, the Neurology sector has seen $4.63B in funding in 2026 to date.

Where does SonALAsense rank among its competitors?

SonALAsense ranks 2nd amongst 4 active competitors, of which 2 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was QV Bioelectronics, which secured $6.05M in Jan, 2026.

Who are the top competitors of SonALAsense?

SonALAsense's top competitors include QV Bioelectronics, SonoTarg and Oratos AI. Among them, QV Bioelectronics secured the most recent funding round in January, 2026.

SonALAsense - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of therapeutic solutions for treating cancer, neurological disorders & others. It has developed a non-invasive drug-device combination therapy, ALA sonodynamic therapy for the treatment of recurrent glioblastoma multiforme disease. It also offers ALA SDT that uses an MRI-guided focused ultrasound device together with a drug, aminolevulinic acid to provide a cancer-specific therapeutic effect. It mainly provides a noninvasive drug-device combination therapy for glioblastoma multiforme, & ALA sonodynamic therapy.

Key Metrics

Founded Year

2019

Location

Berkeley, United States

Stage

Series B

Total Funding

$13.7M in 8 rounds

Latest Funding Round

Grant (prize money), Apr 09, 2025, $*****

Investors

Keiretsu Forum & 2 more

Ranked

2^nd among 4 active competitors

Employee Count

10 as on Aug 31, 2026

Similar Companies

QV Bioelectronics & 2 more

View SonALAsense's full profile

SonALAsense has raised a total funding of $13.7M over 8 rounds. Its first funding round was on Jan 01, 2019. Its latest funding round was a Grant (prize money) round on Apr 09, 2025 for $*****. 1 investor participated in its latest round. SonALAsense has 3 institutional investors.

Here is the list of recent funding rounds of SonALAsense:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 09, 2025	8944164	Grant (prize money)	1979786	7061483	7035706	9845145
Jan 31, 2025	3916901	Grant (prize money)	3957372	1770702	6696712	HHS
Nov 17, 2023	9491140	Conventional Debt	6950085	9875024	2173730	5522602

Access funding benchmarks and valuations. Sign up today!

View details of SonALAsense's funding rounds and investors

The founders of SonALAsense is Stuart Marcus. Stuart Marcus is the CEO of SonALAsense.

Here are the details of SonALAsense's key team members:

Stuart Marcus: Founder & CEO & CMO of SonALAsense.
Contact Info: 1 email address

View details of SonALAsense's Founder profiles and Board Members

SonALAsense's employee count trend

SonALAsense has 10 employees as of Aug 26. Here is SonALAsense's employee count trend over the years:

Uncover SonALAsense's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SonALAsense include QV Bioelectronics, SonoTarg and Oratos AI. Here is the list of Top 10 competitors of SonALAsense, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	QV Bioelectronics 2019, Manchester (United Kingdom), Series A	Manufacturer of electrotherapy devices for treating brain tumors	$9.63M	SOSV, PXN Ventures & 18 others	53/100
2nd	SonALAsense 2019, Berkeley (United States), Series B	Developer of therapeutic solutions for treating cancer, neurological disorders & others	$13.7M	Keiretsu Forum, HHS & 1 others	41/100
3rd	SonoTarg 2017, Belfast (United Kingdom), Unfunded	Provider of sonodynamic therapy and chemotherapy to target cancer	-	-	27/100
4th	Oratos AI Atlanta (United States), Unfunded	Developer of software analyzing spectroscopic imaging for brain tumor treatment	-	-	16/100